ABL Bio Inc
KOSDAQ:298380
Intrinsic Value
The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 9 717.33 KRW. Compared to the current market price of 35 600 KRW, ABL Bio Inc is Overvalued by 73%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
ABL Bio Inc
Fundamental Analysis

Revenue & Expenses Breakdown
ABL Bio Inc
Balance Sheet Decomposition
ABL Bio Inc
Current Assets | 144.2B |
Cash & Short-Term Investments | 140.7B |
Receivables | 1.2B |
Other Current Assets | 2.3B |
Non-Current Assets | 87.8B |
PP&E | 85.4B |
Intangibles | 2.4B |
Other Non-Current Assets | 28m |
Free Cash Flow Analysis
ABL Bio Inc
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
ABL Bio Inc
Revenue
|
33.4B
KRW
|
Operating Expenses
|
-92.8B
KRW
|
Operating Income
|
-59.4B
KRW
|
Other Expenses
|
3.8B
KRW
|
Net Income
|
-55.5B
KRW
|
Profitability Score
Profitability Due Diligence
ABL Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
ABL Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ABL Bio Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
ABL Bio Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ABL Bio Inc
According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 52 275 KRW with a low forecast of 40 400 KRW and a high forecast of 63 000 KRW.
Dividends
Current shareholder yield for ABL Bio Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 9 717.33 KRW.
Compared to the current market price of 35 600 KRW, ABL Bio Inc is Overvalued by 73%.